title: Drotrecogin alfa (activated) in clinical practice and current evidences: reply.
authors.affiliation: Centro de Tratamento Intensivo, Instituto Nacional de Câncer, Rio de Janeiro, RJ, Brasil.
authors.forename: Márcio
authors.initials: M
authors.lastname: Soares
authors.affiliation: Universidade Federal de Santa Catarina, Florianópolis, SC, Brasil.
authors.forename: Fernando Osni
authors.initials: FO
authors.lastname: Machado
authors.affiliation: do Instituto Nacional de Câncer, Rio de Janeiro, RJ, Brasil.
authors.forename: Viviane Bogado Leite
authors.initials: VB
authors.lastname: Torres
authors.affiliation: Centro de Tratamento Intensivo, Núcleo de Pesquisa Clinica em Medicina, Instituto Nacional de Câncer, Rio de Janeiro, RJ, Brasil.
authors.forename: Jorge Ibrain Figueira
authors.initials: JI
authors.lastname: Salluh
authors.affiliation: Unidade de Terapia Intensiva, Hospital Brasília, Brasília, DF, Brasil.
authors.forename: André Carlos Kajdacsy-Balla
authors.initials: AC
authors.lastname: Amaral